
Granules India board approves raising funds up to ₹1,760 crore; Details here
In addition, the board has approved raising up to ₹300 crore through the issuance of 51.28 lakh equity shares at ₹585 per share. These shares…

In addition, the board has approved raising up to ₹300 crore through the issuance of 51.28 lakh equity shares at ₹585 per share. These shares…

Indian rupee opened at 89.64 against the US dollar, rebounding from last week’s 91.0750 low after central bank intervention, with market focus now on key…

Last week, L&T’s buildings and factories business had won large orders from the Madhya Pradesh State Tourism Development Corporation. The company classifies those orders, which…

This is the second fund raise that Coforge has planned over the last 18 months. Previously, the company had raised ₹2,240 crore through the issue…

The newly acquired land parcel at Attibele Hobli has a saleable area of 6.4 msft and a potential gross development value of over ₹4,800 crore.

Nirmal Bang’s Jyoti Gupta said the proposed amalgamation of ACC and Orient Cement could deliver over 12% value accretion for Ambuja shareholders, driven by cost…

Steven Englander, Managing Director and Global Head of G10 FX Research and North American Macro Strategy at Standard Chartered Bank, was decisive on the outlook…

The company said the balance amount will be utilised to meet tax obligations linked to the transaction.

A sum of ₹10,262 crore worth related party transactions have been carried out, including those with Murugappa Group Entities, which merits a closer regulatory scrutiny,…

Cipla had received regulatory approval from the Central Drugs Standard Control Organisation late last year for the exclusive distribution and marketing of Afrezza.